A basic and clinical study on platelet factor 4 (PF4)
Satoh, M.; Endo, Y.; Mamiya, S.
Rinsho Byori. Japanese Journal of Clinical Pathology 30(6): 673-677
1982
ISSN/ISBN: 0047-1860 PMID: 7131839 Document Number: 185216
Document emailed within 1 workday
Related Documents
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276Holt, J.C.; Niewiarowski, S. 1989: Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification Methods in Enzymology 169: 224-233
Lindner, V. 1995: Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury Zeitschrift für Kardiologie 84(Suppl 4): 137-144
Al-Dossari, G.A.; Jessurun, J.; Bolman, R.M.; Kshettry, V.R.; King, M.B.; Murray, J.J.; Hertz, M.I. 1995: Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor Transplantation 59(1): 143-145
Kenagy, R.D.; Hart, C.E.; Stetler-Stevenson, W.G.; Clowes, A.W. 1997: Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9 Circulation 96(10): 3555-3560
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Hirschman, R.J.; Gralnick, H.R. 1974: A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE Journal of Laboratory and Clinical Medicine 84(2): 292-297
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Holmsen, H. 1977: Prostaglandin endoperoxide--thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during "the basic platelet reaction" Thrombosis and Haemostasis 38(4): 1030-1041
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Visscher, D.W.; DeMattia, F.; Ottosen, S.; Sarkar, F.H.; Crissman, J.D. 1995: Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 8(6): 665-670
Heldin, C.H.; Westermark, B. 1993: Possible in vivo effect and clinical utility of platelet-derived growth factor and PDGF antagonists Transplantation Proceedings 25(2): 2074-2076
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Yamada, S.; Yamada, R.; Nakamura, M. 1988: Study on mean platelet volume, platelet distribution width, platelet associated IgG in a family with hereditary thrombocytopenia Rinsho Byori. Japanese Journal of Clinical Pathology 36(6): 667-673
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
De Boissieu, D.; Badoual, J.; Dupont, C.; Chaussade, S.; Denizot, Y.; Benveniste, J. 1991: Study of platelet-activating factor (PAF) in stools of newborn infants with hemorrhagic colitis Archives Francaises de Pediatrie 48(7): 515-516
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320